Form D · Pharmaceuticals
VersaPeutics, Inc.
San Diego, CA · CIK 0001731409
Offering snapshot reported Jul 17, 2020 · SEC filing
- Reported sold
- $0 Indefinite offering
- Investors reported
- 6 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jul 1, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 17, 2020 | Initial | $0 | No comparison | 6 | SEC filing |
| Oct 9, 2018 | Initial | $3,200,000 | No comparison | 4 | SEC filing |
| Jul 9, 2018 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Feb 21, 2018 | Initial | $450,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- Yes
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-371309
Source: Form D, filed Jul 17, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jianhua Cai | Director |
| Haipeng Chen | Director |
| Haipeng Cheng | Director |
| Brian Kwon | Director |
| Connie Zhao | Director |
| Yimin Zou | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
3210 Merryfield Row Jlabs San Diego
San Diego, CA, 92121-1126
San Diego, CA, 92121-1126